Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease

Published:2018-02 Issue:2 Volume:53 Page:96-102
ISSN:1536-0210
Container-title:Investigative Radiology
language:en
Short-container-title:Invest Radiol

Author:

Perez-Lopez Raquel,Nava Rodrigues Daniel,Figueiredo Ines,Mateo Joaquin,Collins David J.,Koh Dow-Mu,de Bono Johann S.,Tunariu Nina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Abiraterone and increased survival in metastatic prostate cancer;N Engl J Med,2011

2. Increased survival with enzalutamide in prostate cancer after chemotherapy;N Engl J Med,2012

3. Alpha emitter radium-223 and survival in metastatic prostate cancer;N Engl J Med,2013

4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;Lancet,2010

5. Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer;J Clin Oncol,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016;European Urology;2024-09

2. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial;European Urology;2024-09

3. Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it;Skeletal Radiology;2024-07-15

4. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on 68Ga-DOTATATE PET/MR;Journal of Cancer Research and Clinical Oncology;2024-05-25

5. Inter- and Intra-Patient Repeatability of Radiomic Features from Multiparametric Whole-Body MRI in Patients with Metastatic Prostate Cancer;Cancers;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3